Neurogene Inc. (NGNE)

CIK 1404644 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Neurogene Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G/A0001493152-26-038383
Aug 14, 2026SCHEDULE 13G/A0001104659-26-097193
Aug 14, 2026SCHEDULE 13G0001172661-26-003430
Aug 11, 20268-K0001404644-26-000056
Aug 11, 202610-Q0001404644-26-000059
Jul 7, 202640001543663-26-000017
Jul 2, 202640001543663-26-000015
Jul 2, 2026424B50001628280-26-046666
Jul 2, 20268-K0001404644-26-000050
Jun 30, 2026424B50001628280-26-046237
Jun 29, 20268-K0001404644-26-000046
Jun 16, 20264/A0001996804-26-000009
Jun 16, 20264/A0001996804-26-000011
Jun 16, 20263/A0001996804-26-000008
Jun 16, 20264/A0001996804-26-000010
Jun 8, 20268-K0001404644-26-000044
Jun 4, 20268-K0001404644-26-000040
May 12, 20268-K0001404644-26-000038
May 12, 202610-Q0001404644-26-000037
May 8, 202640001543663-26-000013
May 7, 202640001934412-26-000006
May 6, 20261440001968582-26-000406
Apr 20, 202630001934412-26-000004
Apr 20, 20268-K0001404644-26-000030
Apr 16, 2026DEF 14A0001404644-26-000027